Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
Introduction: The live-attenuated recombinant vesicular stomatitis virus vaccine expressing the glycoprotein (GP) of Zaire Ebola virus (rVSV-ZEBOV) has proven immunogenic in humans and effective in field studies. Yet long-term durability of vaccine responses is unknown. Areas covered: We survey the...
Saved in:
Main Authors: | Angela Huttner (Author), Claire-Anne Siegrist (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rabies : What We Know and What We Need to Know
by: Sandhu TS
Published: (2004) -
International Trade and Investment and Food Systems: What We Know, What We Don't Know, and What We Don't Know We Don't Know
by: Ashley Schram, et al.
Published: (2021) -
Paediatric schistosomiasis: What we know and what we need to know.
by: Derick N M Osakunor, et al.
Published: (2018) -
The Private Library What We Do Know, What We Don't Know, What We Ought to Know About Our Books
by: Humphreys, Arthur Lee, 1865-1946 -
Towards open science: what we know and what we need to know
by: Álvaro Francisco Lopes de Sousa, et al.